Karyopharm Therapeutics Inc. Quarterly Current Ratio in % from Q2 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Karyopharm Therapeutics Inc. quarterly Current Ratio history and growth rate from Q2 2014 to Q3 2024.
  • Karyopharm Therapeutics Inc. Current Ratio for the quarter ending September 30, 2024 was 325 %, a 34% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 325 -167 -34% Sep 30, 2024
Q2 2024 355 -121 -25.5% Jun 30, 2024
Q1 2024 386 -64.6 -14.3% Mar 31, 2024
Q4 2023 439 +13.7 +3.21% Dec 31, 2023
Q3 2023 492 +108 +27.9% Sep 30, 2023
Q2 2023 477 +94.9 +24.9% Jun 30, 2023
Q1 2023 450 +50.7 +12.7% Mar 31, 2023
Q4 2022 426 +27.4 +6.87% Dec 31, 2022
Q3 2022 385 -35.4 -8.42% Sep 30, 2022
Q2 2022 382 -86.6 -18.5% Jun 30, 2022
Q1 2022 400 -104 -20.7% Mar 31, 2022
Q4 2021 398 -189 -32.1% Dec 31, 2021
Q3 2021 420 -209 -33.2% Sep 30, 2021
Q2 2021 468 -203 -30.3% Jun 30, 2021
Q1 2021 504 -185 -26.9% Mar 31, 2021
Q4 2020 587 -65.2 -10% Dec 31, 2020
Q3 2020 629 -55.7 -8.14% Sep 30, 2020
Q2 2020 672 +39.3 +6.21% Jun 30, 2020
Q1 2020 689 +59.8 +9.51% Mar 31, 2020
Q4 2019 652 +114 +21.2% Dec 31, 2019
Q3 2019 684 +261 +61.7% Sep 30, 2019
Q2 2019 632 +211 +50.2% Jun 30, 2019
Q1 2019 629 +222 +54.5% Mar 31, 2019
Q4 2018 538 +28.4 +5.58% Dec 31, 2018
Q3 2018 423 -301 -41.5% Sep 30, 2018
Q2 2018 421 -386 -47.8% Jun 30, 2018
Q1 2018 407 -391 -49% Mar 31, 2018
Q4 2017 510 -362 -41.5% Dec 31, 2017
Q3 2017 724 -245 -25.3% Sep 30, 2017
Q2 2017 807 -288 -26.3% Jun 30, 2017
Q1 2017 798 -501 -38.6% Mar 31, 2017
Q4 2016 871 -586 -40.2% Dec 31, 2016
Q3 2016 969 -616 -38.9% Sep 30, 2016
Q2 2016 1.09K -836 -43.3% Jun 30, 2016
Q1 2016 1.3K -819 -38.7% Mar 31, 2016
Q4 2015 1.46K -1.02K -41.1% Dec 31, 2015
Q3 2015 1.59K -1.74K -52.4% Sep 30, 2015
Q2 2015 1.93K -824 -29.9% Jun 30, 2015
Q1 2015 2.12K Mar 31, 2015
Q4 2014 2.47K Dec 31, 2014
Q3 2014 3.33K Sep 30, 2014
Q2 2014 2.75K Jun 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.